Metabolomics: Technologies and Global Markets

November 2021 | 157 pages | ID: M062506EDA8EN
BCC Research

Abstracts

Report Scope:

This report examines the current and forecasted market potential for metabolomics. It offers a detailed analysis of the market background, technological advancement, competitive environment, drivers and restraints, and market growth trends. This report includes market projections through 2026, detailing the market share for metabolomics based on product, indication and application type.

By product, the metabolomics market is segmented into separation techniques, detection techniques, assays, and bioinformatics. By indication type, the metabolomics market is segmented into cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and others. The others segment covers respiratory diseases, infectious diseases, etc. By application, the metabolomics market is segmented into biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, and others.

By geography, the metabolomics market has been segmented into Europe, North America, Asia-Pacific (APAC), Latin America, and the Middle East & Africa (MEA). The detailed analyses of major countries such as the U.S., Germany, Canada, the U.K., Spain, Italy, France, Japan, India, and China are found in the regional segments. For market estimates, data is provided for 2020 as the base year, for 2021 and forecast through year-end 2026. Estimated values used are based on metabolomics companies’ total revenues. Projected and forecast revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Report Includes:

• 59 tables
• An overview and industry analysis of the global markets for metabolomics technologies
• Analyses of global market trends, with data from 2019 to 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
• Assessment of the key marketed products and recent product launches, regulatory landscape across different demographics covering North America, Europe, Asia-Pacific, Latin America and Middle East
• Coverage of history and pathways of metabolomics, information on metabolomes and their sources like large bowel microflora, urine metabolome, food metabolome and comparison between lipidomes and lipidomics
• Highlights of the market potential for metabolomics market by product, indication, application, and region; assessment of investment in metabolomic research and spending in pharmaceutical and biotech R&D
• Information on targeted and untargeted approaches for metabolomic technology and complexity associated with data examination and processing
• Identification of leading biotechnology companies poised to introduce products during the forecast period, and their impact on the face of the competitive environment
• Detailed profiles of the leading companies in the metabolomics market, including Agilent Technologies, Bio-Rad, Danaher Corp., Merck KGaA, Promega Corp. and Thermo Fisher Scientific

Contents

CHAPTER 1 INTRODUCTION

Study Goals and Objectives
Reasons for Doing This Study
What's New in This Report
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

CHAPTER 2 SUMMARY AND HIGHLIGHTS

Highlights of the Market for Metabolomics

CHAPTER 3 OVERVIEW OF METABOLOMICS

Introduction
Metabolites
Metabolomics
Metabolomic History
Metabolic Pathways
Metabolomes
Large Bowel Microflora
Urine Metabolome
Food Metabolome
Lipidomes and Lipidomics
Fluxomics
Metabolomic Process Steps
Sample Preparation
Extraction
Derivatization
Separation and Detection
Data Analysis
Metabolomic Technology
Targeted and Untargeted Approaches
Applications

CHAPTER 4 METABOLOMICS: PIPELINE ANALYSIS

Overview

CHAPTER 5 METABOLOMICS: MARKET DYNAMICS

Metabolomics Market Drivers
Increasing Investment in Metabolomic Research
Increase in Demand for Personalized Medicine
Increasing Pharmaceutical and Biotech R&D Spending
Technological Advancements
Increasing Use of Metabolomics in Toxicology Testing
Market Restraints
Complexity Associated with Data Examination and Processing
High Cost of Tools and Instruments
Dearth of Skilled Researchers
Industry Insights
Market Trends

CHAPTER 6 IMPACT OF COVID-19 PANDEMIC

Introduction
Outbreak
Impact of COVID-19 on Metabolomics

CHAPTER 7 GLOBAL METABOLOMICS MARKET BREAKDOWN BY PRODUCT

Introduction
Separation Techniques
Chromatography
Detection Techniques
Mass Spectrometry
Spectroscopy
Assays
Bioinformatics and Systems Biology Tools

CHAPTER 8 GLOBAL METABOLOMICS MARKET BREAKDOWN BY INDICATION

Introduction
Market Breakdown
Cancer
Cardiovascular Disorders
Neurological Disorders
Inborn Errors of Metabolism

CHAPTER 9 GLOBAL METABOLOMICS MARKET BREAKDOWN BY APPLICATION

Introduction
Biomarker Discovery
Drug Discovery
Toxicology Testing
Nutrigenomics
Functional Genomics

CHAPTER 10 GLOBAL METABOLOMICS MARKET BREAKDOWN BY REGION

Introduction
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
Latin America
Middle East and Africa (MEA)

CHAPTER 11 COMPETITIVE LANDSCAPE

Global Company Share Analysis
Mergers and Acquisitions
Agreements, Collaborations, Product Launches, and Partnerships

CHAPTER 12 COMPANY PROFILES

AGILENT TECHNOLOGIES INC.
BIOCRATES LIFE SCIENCES AG
BIO-RAD LABORATORIES INC.
BIOVISION INC.
BRUKER CORP.
CHENOMX
DANAHER CORP.
DRUMETIX LABORATORIES LLC
GERSTEL GMBH & CO. KG
HUMAN METABOLOME TECHNOLOGIES AMERICA INC.
LECO CORP.
MERCK KGAA
METABOLOMIC DIAGNOSTICS
METABOLOMIC TECHNOLOGIES INC.
METABOLON INC.
ONE WAY LIVER GENOMICS S.L.
PERKINELMER INC.
PROMEGA CORP.
QIAGEN N.V.
SHIMADZU CORP.
STEMINA BIOMARKER DISCOVERY INC.
THERMO FISHER SCIENTIFIC INC.

List Of Tables

LIST OF TABLES

Summary Table: Global Market for Metabolomics, by Product Type, Through 2026
Table 1: Publications Referencing Metabolomics, 2008-2018
Table 2: Major Approaches in Metabolomics and their Advantages and Disadvantages
Table 3: Some Pipeline Clinical Trial Studies for Metabolomics
Table 4: Recent Funding Programs in Metabolomics
Table 5: Common Hyphenated Platforms in Metabolomic Research
Table 6: Global Market for Metabolomics, by Product Type, Through 2026
Table 7: Global Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2026
Table 8: Global Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2026
Table 9: Global Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2026
Table 10: Mass Spectroscopy Suppliers for the Life Sciences
Table 11: Global Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2026
Table 12: High-Content Screening Suppliers and Key Attributes
Table 13: Assays Commonly Used with Metabolomic Assays
Table 14: Metabolomic Public Resources
Table 15: Global Market for Metabolomics, by Indication, Through 2026
Table 16: Representation of Pathways, Functions of Metabolites and Possible Biomarkers in Animal Model and Human-Based Studies of Various Neuropsychiatric Disorders
Table 17: Global Market for Metabolomics, by Application, Through 2026
Table 18: Global Market for Metabolomics, by Region, Through 2026
Table 19: North American Market for Metabolomics, by Product Type, Through 2026
Table 20: North American Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2026
Table 21: North American Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2026
Table 22: North American Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2026
Table 23: North American Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2026
Table 24: North American Market for Metabolomic Assays, by Product Type, Through 2026
Table 25: North American Market for Metabolomics, by Indication, Through 2026
Table 26: North American Market for Metabolomics, by Application, Through 2026
Table 27: European Market for Metabolomics, by Product Type, Through 2026
Table 28: European Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2026
Table 29: European Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2026
Table 30: European Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2026
Table 31: European Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2026
Table 32: European Market for Metabolomic Assays, by Product Type, Through 2026
Table 33: European Market for Metabolomics, by Indication, Through 2026
Table 34: European Market for Metabolomics, by Application, Through 2026
Table 35: Asia-Pacific Market for Metabolomics, by Product Type, Through 2026
Table 36: Asia-Pacific Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2026
Table 37: Asia-Pacific Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2026
Table 38: Asia-Pacific Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2026
Table 39: Asia-Pacific Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2026
Table 40: Asia-Pacific Market for Metabolomic Assays, by Product Type, Through 2026
Table 41: Asia-Pacific Market for Metabolomics, by Indication, Through 2026
Table 42: Asia-Pacific Market for Metabolomics, by Application, Through 2026
Table 43: Latin American Market for Metabolomics, by Product Type, Through 2026
Table 44: Latin American Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2026
Table 45: Latin American Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2026
Table 46: Latin American Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2026
Table 47: Latin American Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2026
Table 48: Latin American Market for Metabolomic Assays, by Product Type, Through 2026
Table 49: Latin American Market for Metabolomics, by Indication, Through 2026
Table 50: Latin American Market for Metabolomics, by Application, Through 2026
Table 51: Middle Eastern and African Market for Metabolomics, by Product Type, Through 2026
Table 52: Middle Eastern and African Market for Separation Techniques Applied in Metabolomics, by Product Type, Through 2026
Table 53: Middle Eastern and African Market for Liquid Chromatography Applied in Metabolomics, by Product Type, Through 2026
Table 54: Middle Eastern and African Market for Detection Techniques Applied in Metabolomics, by Product Type, Through 2026
Table 55: Middle Eastern and African Market for Spectroscopy Applied in Metabolomics, by Product Type, Through 2026
Table 56: Middle Eastern and African Market for Metabolomic Assays, by Product Type, Through 2026
Table 57: Middle Eastern and African Market for Metabolomics, by Indication, Through 2026
Table 58: Middle Eastern and African Market for Metabolomics, by Application, Through 2026

List Of Figures

LIST OF FIGURES

Summary Figure: Global Market for Metabolomics, by Product Type, 2020-2026
Figure 1: Publications Referencing Metabolomics, 2008-2018
Figure 2: Cellular Respiration Stages
Figure 3: Factors Impacting Enzyme Activity
Figure 4: Typical Analytical Metabolomic Process Steps
Figure 5: Schematic Representation of a Metabolomic Workflow
Figure 6: Bioinformatic Processes for Metabolomics
Figure 7: Global Market for Metabolomics, by Region, 2020
Figure 8: Global Metabolomics Market Share Analysis, by Company, 2020
Figure 9: Agilent: Annual Revenue, 2018-2020
Figure 10: Agilent: Revenue Share, by Geography, 2020
Figure 11: Agilent: Revenue Share, by Segment, 2020
Figure 12: Bio-Rad: Annual Revenue, 2018-2020
Figure 13: Bio-Rad: Revenue Share, by Segment, 2020
Figure 14: Bruker: Annual Revenue, 2018-2020
Figure 15: Bruker: Revenue Share, by Region, 2020
Figure 16: Danaher Corp.: Annual Revenue, 2018-2020
Figure 17: Danaher Corp.: Revenue Share, by Geography, 2020
Figure 18: Danaher Corp.: Revenue Share, by Segment, 2020
Figure 19: Merck KGaA: Annual Revenue, 2019 and 2020
Figure 20: Merck KGaA: Revenue Share, by Region, 2020
Figure 21: Merck KGaA: Revenue Share, by Segment, 2020
Figure 22: Thermo Fisher Scientific: Annual Revenue, 2019 and 2020
Figure 23: Thermo Fisher Scientific: Revenue Share, by Segment, 2020